Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 4,067 | 1,586 | 1,485 | 1,090 | 850 |
| Gross Profit | 4,067 | 1,586 | 1,485 | 1,090 | 850 |
| Operating Expenses | 34,377 | 33,578 | 31,080 | 23,646 | 22,048 |
| Operating Income | -30,310 | -31,992 | -29,595 | -22,556 | -21,198 |
| Other Income | 302 | 181 | 137 | 95 | 88 |
| Pre-tax Income | -30,008 | -31,811 | -29,458 | -22,461 | -21,110 |
| Net Income Continuous | -30,008 | -31,811 | -29,458 | -22,461 | -21,110 |
| Net Income | $-30,008 | $-31,811 | $-29,458 | $-22,461 | $-21,110 |
| EPS Basic Total Ops | -12.60 | -16.60 | -15.80 | -12.00 | -11.60 |
| EPS Basic Continuous Ops | -12.68 | -16.62 | -15.88 | -12.19 | -11.51 |
| EPS Diluted Total Ops | -12.60 | -16.60 | -15.80 | -12.00 | -11.60 |
| EPS Diluted Continuous Ops | -12.68 | -16.62 | -15.88 | -12.19 | -11.51 |
| EBITDA(a) | $-30,196 | $-31,881 | $-29,505 | $-22,482 | $-21,126 |